Table of Contents:
  • Foreword / Claude Lenfant
  • 1. Cholesterol-Lowering Clinical Trials: A Historical Perspective / Scott M. Grundy
  • 2. Scandinavian Simvastatin Survival Study (4S) / Terje R. Pedersen
  • 3. Cholesterol and Recurrent Events Trial (CARE): The Effect of Pravastatin on Coronary Events After Myocardial Infarction in Patients with Average Cholesterol Levels / Frank M. Sacks, Marc A. Pfeffer and Lemuel A. Moye / [and others]
  • 4. Lessons from the West of Scotland Coronary Prevention Study (WOSCOPS) / James Shepherd and Allan Gaw
  • 5. Program on the Surgical Control of the Hyperlipidemias (POSCH) Trial: A Pivotal 25-Year Study / Henry Buchwald
  • 6. The Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): Primary Prevention of Acute Major Coronary Events in Women and Men with Average Cholesterol / Stephen Weis, Michael Clearfield and John R. Downs / [and others]
  • 7. Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study: Clinical Implications for Cardiovascular Practice / Andrew M. Tonkin and David Hunt
  • 8. Angiographic Results of Lipid-Lowering Trials: A Systematic Review and Meta-Analysis / Cheryl L. Holmes, Michael Schulzer and G.B. John Mancini
  • 9. Biochemical Correlates of Plaque Progression and Coronary Events / Melissa Ferraro-Borgida and David Waters
  • 10. Lipid Therapy to Stabilize the Vulnerable Atherosclerotic Plaque: New Insights into the Prevention of Cardiovascular Events / B. Greg Brown and Xue-Qiao Zhao
  • 11. Cholesterol-Lowering Trials with Carotid Ultrasonographic Outcomes / Robert P. Byington
  • 12. Cholesterol Lowering Reduces Mortality: The Statins / David J. Gordon.